Physician

Matthew Thomas Hoffmann, MD

According to 2025 Medicare claims, Matthew Hoffmann, MD (NPI: 1609132976) practices dermatology in the Longview, TX market, with the plurality of this provider's patient population coming from Gregg, TX. This provider's primary affiliated billing organization is OLIVER STREET 5.01(A) INC. (NPI: 1457695413; TIN: 461314303) and primary practice location at 75601-4774.

Hoffmann's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 821 traditional Medicare patients, billed 4,686 HCPCS/CPT codes, and received $558,601 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 975 prescription claims across 509 beneficiaries totaling $428,906 in drug costs, led by Tremfya (Guselkumab). Open Payments data shows 119 records totaling $21,372. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $634,699 and ending at $428,906. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$279K$559K2016 Medicare payment: $66,915 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $504,110 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $538,819 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $516,783 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $430,405 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $493,753 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $489,308 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $491,702 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $558,601 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016102482$66,915
20177854,214$504,110
20188906,664$538,819
20199677,572$516,783
20208675,728$430,405
20218746,496$493,753
20229136,655$489,308
20239405,237$491,702
20248214,686$558,601

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$317K$635K2015 Drug cost: $634,699 (USD; Tot_Drug_Cst)2016 Drug cost: $234,701 (USD; Tot_Drug_Cst)2017 Drug cost: $25,318 (USD; Tot_Drug_Cst)2018 Drug cost: $260,363 (USD; Tot_Drug_Cst)2019 Drug cost: $174,735 (USD; Tot_Drug_Cst)2020 Drug cost: $379,969 (USD; Tot_Drug_Cst)2021 Drug cost: $565,598 (USD; Tot_Drug_Cst)2022 Drug cost: $400,812 (USD; Tot_Drug_Cst)2023 Drug cost: $460,714 (USD; Tot_Drug_Cst)2024 Drug cost: $428,906 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201557209$634,699
201679159$234,701
2017329484$25,318
2018444879$260,363
20194991,028$174,735
20204441,015$379,969
20215341,235$565,598
20225091,115$400,812
20235831,256$460,714
2024509975$428,906

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks355448$469
17110Destruction of skin growth, 1-14 growths147168$82
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more424607$60
17000Destruction of precancer skin growth, 1 growth315402$38
17003Destruction of precancer skin growth, 2-14 growths2501,602$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TremfyaGuselkumab11616$151,246
Clobetasol PropionateClobetasol Propionate701,853$2,715
Doxycycline HyclateDoxycycline Hyclate2122,473$1,653
MupirocinMupirocin2103,982$1,458
Triamcinolone AcetonideTriamcinolone Acetonide1173,422$1,240

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.114$2,252Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.5$19,120ABBVIE INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Matthew Thomas Hoffmann, MD?

Tedicare shows public-source Medicare data for Matthew Thomas Hoffmann, MD (NPI 1609132976), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Thomas Hoffmann, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Matthew Thomas Hoffmann, MD?

Matthew Thomas Hoffmann, MD is linked to OLIVER STREET 5.01(A) INC. (billing NPI 1457695413) in the available physician profile data.

Does Matthew Thomas Hoffmann, MD have Open Payments data?

Matthew Thomas Hoffmann, MD has 119 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.